Journal article
Adding cisplatin to ifosfamide may improve progression-free survival but greatly increases toxicity in women with carcinosarcoma of the uterus
Authors
Elit L
Journal
Evidence-based Oncology, Vol. 2, No. 3, pp. 142–144
Publisher
Elsevier
Publication Date
January 1, 2001
DOI
10.1054/ebon.2001.0130
ISSN
1363-4054